Tresiba Trial Shows That People With Type 2 Diabetes who Avoid Severe Hypoglycaemia Have a Reduced Risk of Death
BioTech Gate,
/PRNewswire/ -- Novo Nordisk today announced new analyses from the DEVOTE trial showing that people with type 2 diabetes who…